Skip to main content

Meiji Yasuda Asset Management Co Ltd.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1491685 Tokyo, M0

Position in NBIX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$895,284
+$195,482 QoQ
Shares Held
5,312
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#413
of 768 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Meiji Yasuda Asset Management Co Ltd. holds $7,960,715 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (11.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
5,312 $895,284

All Filings in NBIX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $895,284 5,312
2026-03-31 $699,802 5,312
2025-12-31 $749,571 5,285
2025-09-30 $755,104 5,379
2025-06-30 $728,122 5,793
2025-03-31 $762,255 6,892
2024-12-31 $990,990 7,260
2024-09-30 $836,497 7,260
2024-06-30 $1,002,788 7,284
2024-03-31 $869,999 6,308
2023-12-31 $1,191,110 9,040
2023-09-30 $891,000 7,920
2023-06-30 $277,242 2,940
2023-03-31 $238,879 2,360
2022-12-31 $751,277 6,290
2022-09-30 $668,060 6,290
2022-06-30 $626,796 6,430
2022-03-31 $591,562 6,310
2021-12-31 $547,643 6,430
2021-03-31 $476,525 4,900
2020-12-31 $430,366 4,490